A Review of Recent Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hepatocellular Carcinoma
Medical Science Monitor · 23.06.2026 · 32
DOI: 10.12659/msm.953528 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Science Monitor, online erschienen am 23.06.2026. Verfasst von Xiaopan Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.
- Department of Gastroenterology, Linyi People's Hospital, Linyi, Shandong, China.
Zitieren
APA
Lv, X., Chen, X., Ge, Y., Si, G., Li, Y., Li, X., & Yuan, X. (2026). A Review of Recent Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hepatocellular Carcinoma. Medical Science Monitor, 32. https://doi.org/10.12659/msm.953528
Vancouver
Lv X, Chen X, Ge Y, Si G, Li Y, Li X, et al. A Review of Recent Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hepatocellular Carcinoma. Medical Science Monitor. 2026;32. doi:10.12659/msm.953528
BibTeX
@article{Lv2026,
author = {Lv, Xiaopan and Chen, Xuemei and Ge, Yuxin and Si, Guifei and Li, Yuquan and Li, Xiuping and Yuan, Xuemin},
title = {A Review of Recent Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hepatocellular Carcinoma},
journal = {Medical Science Monitor},
year = {2026},
volume = {32},
doi = {10.12659/msm.953528}
}
EUVIMED